Analysis Suggests That Improvements In Kidney Function In Patients Treated With Lipitor Strongly Correlate With A Reduced Risk Of Cardiovascular Event

Improvements in kidney function in patients treated with LIPITOR*® (atorvastatin calcium) were shown to strongly correlate with a reduced risk of major cardiovascular events in patients with pre-existing cardiovascular disease, according to a post hoc sub-analysis of the five-year Treating to New Targets (TNT) study presented on 12 November, 2008 at the Annual Scientific Sessions of the American Heart Association.

More: continued here

Filed under: Cardiovascular on November 21st, 2008